Table 1 Descriptive characteristics of the study population.
From: Interplay between age, APOE Ɛ4 and the metabolome in plasma and brain in Alzheimer’s disease
Descriptive Statistics | Dementia | Alzheimers (AD) | Vascular dementia (VAD) | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
Characteristics | Total (n = 119419) | No (n = 116011) | Yes (n = 3344) | p-value | No (n = 117826) | Yes (n = 1582) | p-value | No (n = 118541) | Yes (n = 878) | p-value |
Recruitment age, Median (Q1,Q3) | 64 (62, 66) | 64 (62, 66) | 66 (64, 68) | <0.001 | 64 (62, 66) | 66 (64, 68) | <0.001 | 64 (62, 66) | 66 (64, 68) | <0.001 |
Sex, n (%) | <0.001 | 0.219 | <0.001 | |||||||
Female | 62641 (52) | 61064 (53) | 1547 (46) | 61823 (52) | 805 (51) | 62297 (53) | 344 (39) | |||
Male | 56778 (48) | 54947 (47) | 1797 (54) | 56003 (48) | 777 (49) | 56244 (47) | 534 (61) | |||
Smoking status, n (%) | <0.001 | 0.099 | <0.001 | |||||||
Never | 59042 (50) | 57505 (50) | 1505 (45) | 58290 (50) | 747 (48) | 58673 (50) | 369 (42) | |||
Previous | 49923 (42) | 48384 (42) | 1511 (46) | 49222 (42) | 698 (45) | 49512 (42) | 411 (47) | |||
Current | 9757 (8) | 9462 (8) | 292 (9) | 9638 (8) | 118 (8) | 9668 (8) | 89 (10) | |||
Alcohol_freq, n (%) | <0.001 | <0.001 | <0.001 | |||||||
Never | 10115 (8) | 9632 (8) | 472 (14) | 9904 (8) | 211 (13) | 9988 (8) | 127 (14) | |||
Special occasions only | 14441 (12) | 13947 (12) | 485 (15) | 14213 (12) | 224 (14) | 14322 (12) | 119 (14) | |||
One to three times a month | 11932 (10) | 11589 (10) | 333 (10) | 11781 (10) | 149 (9) | 11846 (10) | 86 (10) | |||
Once or twice a week | 28784 (24) | 28026 (24) | 747 (22) | 28379 (24) | 400 (25) | 28579 (24) | 205 (23) | |||
Three or four times a week | 26405 (22) | 25767 (22) | 632 (19) | 26109 (22) | 296 (19) | 26243 (22) | 162 (18) | |||
Daily or almost daily | 27544 (23) | 26864 (23) | 664 (20) | 27248 (23) | 297 (19) | 27366 (23) | 178 (20) | |||
Body mass index, Median (Q1,Q3) | 27.02 (24.52, 29.99) | 27.02 (24.52, 29.98) | 27.18 (24.52, 30.39) | 0.101 | 27.02 (24.52, 30) | 26.94 (24.28, 29.86) | 0.045 | 27.02 (24.51, 29.98) | 27.8 (25.15, 31.24) | <0.001 |
Physical activity (IPAQ), n (%) | <0.001 | 0.445 | <0.001 | |||||||
low | 16221 (17) | 15700 (17) | 506 (20) | 16024 (17) | 196 (17) | 16067 (17) | 154 (23) | |||
moderate | 39043 (42) | 38004 (42) | 1025 (41) | 38560 (42) | 478 (40) | 38788 (42) | 255 (38) | |||
high | 38691 (41) | 37706 (41) | 971 (39) | 38181 (41) | 508 (43) | 38434 (41) | 257 (39) | |||
Ethnicity, n (%) | <0.001 | 0.003 | <0.001 | |||||||
British | 110109 (93) | 107014 (93) | 3035 (91) | 108656 (93) | 1444 (92) | 109312 (93) | 797 (91) | |||
White | 129 (0) | 120 (0) | 9 (0) | 122 (0) | 6 (0) | 127 (0) | 2 (0) | |||
Mixed | 12 (0) | 11 (0) | 1 (0) | 11 (0) | 1 (0) | 12 (0) | 0 (0) | |||
Asian or Asian British | 5 (0) | 5 (0) | 0 (0) | 5 (0) | 0 (0) | 5 (0) | 0 (0) | |||
Black or Black British | 4 (0) | 3 (0) | 1 (0) | 4 (0) | 0 (0) | 3 (0) | 1 (0) | |||
Chinese | 145 (0) | 145 (0) | 0 (0) | 145 (0) | 0 (0) | 145 (0) | 0 (0) | |||
Other ethnic group | 500 (0) | 489 (0) | 11 (0) | 496 (0) | 4 (0) | 496 (0) | 4 (0) | |||
Irish | 2871 (2) | 2754 (2) | 116 (3) | 2827 (2) | 44 (3) | 2834 (2) | 37 (4) | |||
Any other white background | 2746 (2) | 2685 (2) | 61 (2) | 2718 (2) | 28 (2) | 2729 (2) | 17 (2) | |||
White and Black Caribbean | 47 (0) | 43 (0) | 4 (0) | 45 (0) | 2 (0) | 46 (0) | 1 (0) | |||
White and Black African | 41 (0) | 41 (0) | 0 (0) | 41 (0) | 0 (0) | 41 (0) | 0 (0) | |||
White and Asian | 91 (0) | 90 (0) | 1 (0) | 91 (0) | 0 (0) | 90 (0) | 1 (0) | |||
Any other mixed background | 127 (0) | 123 (0) | 4 (0) | 123 (0) | 4 (0) | 127 (0) | 0 (0) | |||
Indian | 854 (1) | 830 (1) | 24 (1) | 845 (1) | 9 (1) | 850 (1) | 4 (0) | |||
Pakistani | 178 (0) | 173 (0) | 5 (0) | 175 (0) | 3 (0) | 178 (0) | 0 (0) | |||
Bangladeshi | 14 (0) | 14 (0) | 0 (0) | 14 (0) | 0 (0) | 14 (0) | 0 (0) | |||
Any other Asian background | 220 (0) | 214 (0) | 6 (0) | 216 (0) | 4 (0) | 220 (0) | 0 (0) | |||
Caribbean | 502 (0) | 469 (0) | 33 (1) | 483 (0) | 19 (1) | 497 (0) | 5 (1) | |||
African | 288 (0) | 278 (0) | 10 (0) | 284 (0) | 4 (0) | 281 (0) | 7 (1) | |||
Any other Black background | 7 (0) | 6 (0) | 1 (0) | 7 (0) | 0 (0) | 6 (0) | 1 (0) | |||
Volume hippocampus (Left), Median (Q1,Q3) | 3762.9 (3520.5, 4034.07) | 3763.9 (3522.98, 4034.65) | 3476.8 (3283.5, 3704.9) | <0.001 | 3763.3 (3522.5, 4034.4) | 3476.8 (3262.7, 3583.8) | <0.001 | 3763.3 (3521.2, 4034.3) | 3476.8 (3425.3, 3654.2) | 0.009 |
Volume hippocampus (Right), Median (Q1,Q3) | 3927.25 (3666.62, 4205.65) | 3928.15 (3668.85, 4205.98) | 3568.7 (3328.65, 3860.2) | <0.001 | 3927.7 (3667.9, 4205.8) | 3463.7 (3229.9, 3810.8) | <0.001 | 3927.6 (3667.2, 4205.8) | 3657.6 (3337.2, 3796.5) | 0.008 |
Volume entorhinal cortex (Right), Median (Q1,Q3) | 1789 (1561, 2051) | 1789.5 (1561, 2052) | 1641 (1403, 1842) | 0.005 | 1789 (1561, 2052) | 1543 (1369, 1815) | 0.061 | 1789 (1561, 2052) | 1603 (1439, 1722) | 0.019 |
Volume entorhinal cortex (Left), Median (Q1,Q3) | 1911.5 (1661, 2186.75) | 1912 (1661.25, 2187) | 1685 (1493, 2078) | 0.023 | 1912 (1661, 2187) | 1836 (1478, 2067) | 0.195 | 1912 (1661, 2187) | 1634 (1488, 1834) | 0.028 |
Headsize, Median (Q1,Q3) | 1.28 (1.2, 1.37) | 1.28 (1.2, 1.37) | 1.31 (1.21, 1.39) | 0.408 | 1.28 (1.2, 1.37) | 1.32 (1.21, 1.38) | 0.392 | 1.28 (1.2, 1.37) | 1.33 (1.32, 1.4) | 0.089 |
Fractional anisotropy cingulum parahippocampus (Right), Median (Q1,Q3) | 0.46 (0.43, 0.48) | 0.46 (0.43, 0.48) | 0.45 (0.42, 0.46) | 0.027 | 0.46 (0.43, 0.48) | 0.42 (0.4, 0.44) | 0.002 | 0.46 (0.43, 0.48) | 0.48 (0.45, 0.48) | 0.387 |
Fractional anisotropy cingulum parahippocampus (Left), Median (Q1,Q3) | 0.46 (0.43, 0.48) | 0.46 (0.43, 0.48) | 0.44 (0.43, 0.47) | 0.096 | 0.46 (0.43, 0.48) | 0.42 (0.41, 0.44) | 0.002 | 0.46 (0.43, 0.48) | 0.47 (0.46, 0.47) | 0.372 |
Mean diffusivity cingulum parahippocampus (Left), Median (Q1,Q3) | 0 .000762(0.000738, 0.000787) | 0 .000762(0.000738, 0.000787) | 0.000781 (0.000741, 0.00082) | 0.048 | 0.000762(0.000738,0.000787) | 0.000816 (0.000784, 0.000844) | 0.001 | 0.000762(0.000738, 0.000787) | 0.000723 (0.000721, 0.000768) | 0.13 |
Mean diffusivity cingulum parahippocampus (Right), Median (Q1,Q3) | 0.000765(0.000742, 0.000789) | 0.000765 (0.000742, 0.000787) | 0 .000781(0.000746, 0.00082) | 0.036 | 0.000765 (0.000742, 0.000789) | 0.000814(0.000803, 0.000818) | <0.001 | 0.000765(0.000742, 0.000789) | 0.000740 (0.000727, 0.000771) | 0.247 |
Reaction time, Median (Q1,Q3) | 567 (508, 645) | 567 (508, 645) | 597 (528, 687) | <0.001 | 567 (508, 645) | 590 (527, 680) | <0.001 | 567 (508, 645) | 613 (539, 695) | <0.001 |
Fluid intelligence, Median (Q1,Q3) | 6 (4, 7) | 6 (4, 7) | 5 (4, 7) | <0.001 | 6 (4, 7) | 5 (4, 6) | <0.001 | 6 (4, 7) | 5 (3, 6) | <0.001 |
Handgrip strength (Left), Median (Q1,Q3) | 26 (20, 36) | 26 (20, 36) | 26 (18, 34) | <0.001 | 26 (20, 36) | 25 (18, 34) | <0.001 | 26 (20, 36) | 28 (20, 36) | 0.859 |
Handgrip strength (Right), Median (Q1,Q3) | 28 (22, 38) | 28 (22, 38) | 28 (21, 37) | <0.001 | 28 (22, 38) | 28 (20, 36) | <0.001 | 28 (22, 38) | 30 (22, 38) | 0.886 |
AD_time, Median (Q1,Q3) | 4538 (4229, 4812) | 4546 (4241, 4816) | 4122 (3308.25, 4583) | <0.001 | 4544 (4237, 4815) | 3621 (2838.5, 4167) | <0.001 | 4539 (4230, 4812) | 4237 (3500.5, 4670) | <0.001 |
dementia_time, Median (Q1,Q3) | 4531 (4224, 4810) | 4546 (4242, 4816) | 3608.5 (2854, 4196) | <0.001 | 4539 (4230, 4812) | 3617 (2858, 4215.5) | <0.001 | 4537 (4228, 4812) | 3491 (2749, 4128) | <0.001 |
VAD_time, Median (Q1,Q3) | 4541 (4231, 4814) | 4546 (4242, 4816) | 4260 (3518, 4678) | <0.001 | 4543 (4235, 4814.5) | 4355.5 (3741.75, 4726.25) | <0.001 | 4544 (4236, 4815) | 3640.5 (2926.75, 4228.5) | <0.001 |
Fasting time (hrs), Median (Q1,Q3) | 3 (3, 4) | 3 (3, 4) | 4 (3, 5) | <0.001 | 3 (3, 4) | 4 (3, 5) | <0.001 | 3 (3, 4) | 4 (3, 5) | <0.001 |
Medication use | ||||||||||
Antidiabetics (A10), n (%) | <0.001 | <0.001 | <0.001 | |||||||
No | 113349 (95) | 110334 (95) | 2964 (89) | 111911 (95) | 1425 (90) | 112609 (95) | 740 (84) | |||
Yes | 6070 (5) | 5677 (5) | 380 (11) | 5915 (5) | 157 (10) | 5932 (5) | 138 (16) | |||
Antihypertensives (C02), n (%) | <0.001 | 0.047 | <0.001 | |||||||
No | 116582 (98) | 113313 (98) | 3207 (96) | 115040 (98) | 1532 (97) | 115746 (98) | 836 (95) | |||
Yes | 2837 (2) | 2698 (2) | 137 (4) | 2786 (2) | 50 (3) | 2795 (2) | 42 (5) | |||
Diuretics (C03), n (%) | <0.001 | 0.156 | <0.001 | |||||||
No | 104407 (87) | 101535 (88) | 2820 (84) | 103031 (87) | 1364 (86) | 103704 (87) | 703 (80) | |||
Yes | 15012 (13) | 14476 (12) | 524 (16) | 14795 (13) | 218 (14) | 14837 (13) | 175 (20) | |||
Beta blocking agents (C07), n (%) | <0.001 | <0.001 | <0.001 | |||||||
No | 106139 (89) | 103304 (89) | 2780 (83) | 104777 (89) | 1355 (86) | 105456 (89) | 683 (78) | |||
Yes | 13280 (11) | 12707 (11) | 564 (17) | 13049 (11) | 227 (14) | 13085 (11) | 195 (22) | |||
Calcium channel blockers (C08), n (%) | <0.001 | 0.002 | <0.001 | |||||||
No | 105519 (88) | 102679 (89) | 2790 (83) | 104144 (88) | 1358 (86) | 104831 (88) | 688 (78) | |||
Yes | 13900 (12) | 13332 (11) | 554 (17) | 13682 (12) | 224 (14) | 13710 (12) | 190 (22) | |||
Renin-angiotensin system drugs (C09), n (%) | <0.001 | <0.001 | <0.001 | |||||||
No | 94239 (79) | 91844 (79) | 2352 (70) | 93053 (79) | 1177 (74) | 93700 (79) | 539 (61) | |||
Yes | 25180 (21) | 24167 (21) | 992 (30) | 24773 (21) | 405 (26) | 24841 (21) | 339 (39) | |||
Lipid lowering (C10), n (%) | <0.001 | <0.001 | <0.001 | |||||||
No | 81670 (68) | 79753 (69) | 1886 (56) | 80716 (69) | 944 (60) | 81258 (69) | 412 (47) | |||
Yes | 37749 (32) | 36258 (31) | 1458 (44) | 37110 (31) | 638 (40) | 37283 (31) | 466 (53) | |||
Opioids (N02A), n (%) | <0.001 | <0.001 | <0.001 | |||||||
No | 111323 (93) | 108324 (93) | 2946 (88) | 109901 (93) | 1414 (89) | 110564 (93) | 759 (86) | |||
Yes | 8096 (7) | 7687 (7) | 398 (12) | 7925 (7) | 168 (11) | 7977 (7) | 119 (14) | |||
Analgesics & antipyretics (N02B), n (%) | <0.001 | <0.001 | <0.001 | |||||||
No | 77513 (65) | 75708 (65) | 1773 (53) | 76612 (65) | 891 (56) | 77114 (65) | 399 (45) | |||
Yes | 41906 (35) | 40303 (35) | 1571 (47) | 41214 (35) | 691 (44) | 41427 (35) | 479 (55) | |||
Antimigraine (N02C), n (%) | 0.074 | 0.104 | 0.911 | |||||||
No | 118218 (99) | 114833 (99) | 3321 (99) | 116634 (99) | 1573 (99) | 117348 (99) | 870 (99) | |||
Yes | 1201 (1) | 1178 (1) | 23 (1) | 1192 (1) | 9 (1) | 1193 (1) | 8 (1) | |||
Antiepileptics (N03A), n (%) | <0.001 | <0.001 | <0.001 | |||||||
No | 117262 (98) | 114005 (98) | 3199 (96) | 115727 (98) | 1527 (97) | 116437 (98) | 825 (94) | |||
Yes | 2157 (2) | 2006 (2) | 145 (4) | 2099 (2) | 55 (3) | 2104 (2) | 53 (6) | |||
Anticholinergics (N04A), n (%) | <0.001 | 0.025 | 0.454 | |||||||
No | 119337 (100) | 115940 (100) | 3335 (100) | 117747 (100) | 1578 (100) | 118460 (100) | 877 (100) | |||
Yes | 82 (0) | 71 (0) | 9 (0) | 79 (0) | 4 (0) | 81 (0) | 1 (0) | |||
Dopaminergic (N04B), n (%) | <0.001 | <0.001 | 0.053 | |||||||
No | 118965 (100) | 115672 (100) | 3235 (97) | 117393 (100) | 1561 (99) | 118094 (100) | 871 (99) | |||
Yes | 454 (0) | 339 (0) | 109 (3) | 433 (0) | 21 (1) | 447 (0) | 7 (1) | |||
Antipsychotics (N05A), n (%) | <0.001 | 0.077 | <0.001 | |||||||
No | 118488 (99) | 115138 (99) | 3292 (98) | 116913 (99) | 1563 (99) | 117626 (99) | 862 (98) | |||
Yes | 931 (1) | 873 (1) | 52 (2) | 913 (1) | 19 (1) | 915 (1) | 16 (2) | |||
Anxiolytics (N05B), n (%) | <0.001 | 0.005 | 0.122 | |||||||
No | 118883 (100) | 115508 (100) | 3314 (99) | 117304 (100) | 1567 (99) | 118012 (100) | 871 (99) | |||
Yes | 536 (0) | 503 (0) | 30 (1) | 522 (0) | 15 (1) | 529 (0) | 7 (1) | |||
Hypnotics & sedatives (N05C), n (%) | <0.001 | 0.181 | 0.003 | |||||||
No | 118327 (99) | 114978 (99) | 3289 (98) | 116754 (99) | 1562 (99) | 117466 (99) | 861 (98) | |||
Yes | 1092 (1) | 1033 (1) | 55 (2) | 1072 (1) | 20 (1) | 1075 (1) | 17 (2) | |||
Antidepressants (N06A), n (%) | <0.001 | <0.001 | <0.001 | |||||||
No | 110795 (93) | 107846 (93) | 2902 (87) | 109408 (93) | 1381 (87) | 110053 (93) | 742 (85) | |||
Yes | 8624 (7) | 8165 (7) | 442 (13) | 8418 (7) | 201 (13) | 8488 (7) | 136 (15) | |||
Psychostimulants (N06B), n (%) | 0.574 | 1 | 1 | |||||||
No | 119389 (100) | 115982 (100) | 3343 (100) | 117796 (100) | 1582 (100) | 118511 (100) | 878 (100) | |||
Yes | 30 (0) | 29 (0) | 1 (0) | 30 (0) | 0 (0) | 30 (0) | 0 (0) | |||
Psycholeptics (N06C), n (%) | 0.113 | 0.429 | 0.267 | |||||||
No | 119377 (100) | 115972 (100) | 3341 (100) | 117785 (100) | 1581 (100) | 118500 (100) | 877 (100) | |||
Yes | 42 (0) | 39 (0) | 3 (0) | 41 (0) | 1 (0) | 41 (0) | 1 (0) | |||
Anti dementia drugs (N06D), n (%) | <0.001 | <0.001 | 0.08 | |||||||
No | 118373 (99) | 115034 (99) | 3287 (98) | 116826 (99) | 1544 (98) | 117508 (99) | 865 (99) | |||
Yes | 1046 (1) | 977 (1) | 57 (2) | 1000 (1) | 38 (2) | 1033 (1) | 13 (1) | |||
Parasympathomimetics (N07A), n (%) | 0.138 | 0.612 | 1 | |||||||
No | 119348 (100) | 115944 (100) | 3340 (100) | 117756 (100) | 1581 (100) | 118470 (100) | 878 (100) | |||
Yes | 71 (0) | 67 (0) | 4 (0) | 70 (0) | 1 (0) | 71 (0) | 0 (0) | |||
Drugs for addictive disorders (N07B), n (%) | <0.001 | 0.005 | 0.006 | |||||||
No | 119266 (100) | 115872 (100) | 3330 (100) | 117679 (100) | 1575 (100) | 118393 (100) | 873 (99) | |||
Yes | 153 (0) | 139 (0) | 14 (0) | 147 (0) | 7 (0) | 148 (0) | 5 (1) | |||
Antivertigo preparations (N07C), n (%) | 0.002 | 0.003 | 0.011 | |||||||
No | 118752 (99) | 115377 (99) | 3312 (99) | 117177 (99) | 1564 (99) | 117885 (99) | 867 (99) | |||
Yes | 667 (1) | 634 (1) | 32 (1) | 649 (1) | 18 (1) | 656 (1) | 11 (1) | |||
Anesthetics (N01A), n (%) | 1 | 1 | 1 | |||||||
No | 119366 (100) | 115959 (100) | 3343 (100) | 117773 (100) | 1582 (100) | 118488 (100) | 878 (100) | |||
Yes | 53 (0) | 52 (0) | 1 (0) | 53 (0) | 0 (0) | 53 (0) | 0 (0) | |||
Proton pump inhibitors (A02BC), n (%) | <0.001 | <0.001 | <0.001 | |||||||
No | 102449 (86) | 99701 (86) | 2702 (81) | 101140 (86) | 1298 (82) | 101772 (86) | 677 (77) | |||
Yes | 16970 (14) | 16310 (14) | 642 (19) | 16686 (14) | 284 (18) | 16769 (14) | 201 (23) | |||
Digitalis glycosides (C01AA), n (%) | <0.001 | 0.057 | <0.001 | |||||||
No | 118864 (100) | 115486 (100) | 3314 (99) | 117282 (100) | 1569 (99) | 118002 (100) | 862 (98) | |||
Yes | 555 (0) | 525 (0) | 30 (1) | 544 (0) | 13 (1) | 539 (0) | 16 (2) | |||
Platelet aggregation inhibitors (B01AC), n (%) | <0.001 | <0.001 | <0.001 | |||||||
No | 92890 (78) | 90617 (78) | 2233 (67) | 91769 (78) | 1108 (70) | 92395 (78) | 495 (56) | |||
Yes | 26529 (22) | 25394 (22) | 1111 (33) | 26057 (22) | 474 (30) | 26146 (22) | 383 (44) | |||